2009
DOI: 10.1203/pdr.0b013e3181b33392
|Get access via publisher |Summarize |Cite
|
Sign up to set email alerts

Asymmetric Dimethylarginine in the Maternal and Fetal Circulation in Preeclampsia

Abstract: Preeclampsia is a leading cause of intrauterine growth restriction and preterm birth. Endothelial dysfunction is the common final pathway leading to clinical signs of preeclampsia including hypertension and proteinuria. Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of NOS and induces endothelial dysfunction by reversibly inhibiting NO production from L-arginine. The purpose of this study was to investigate maternal and fetal concentrations of ADMA, L-arginine, and symmetric dimethylarginine (SD… Show more

Search citation statements

Order By: Relevance

Paper Sections

Select...
45
10
8
2

Citation Types

4
44
0
0

Year Published

Range
2010
2010
2026
2026

Publication Types

Select...
60
2

Relationship

0
62

Authors

Journals

citations

Cited by 62 publications

(48 citation statements)
references

References 41 publications

4
44
0
0
Order By: Relevance
How this paper cites the one you are viewing
“…We found progressive increases in the ADMA, blood pressure parameters, and heart rate throughout gestation in the overall high-risk cohort, which is consistent with endothelial dysfunction and accumulating cardiovascular strain. These results are consistent with earlier studies showing that elevated ADMA levels during pregnancy are a sign of endothelial stress [ 20 , 22 ]. On the other hand, the cfPWV stayed constant during pregnancy, indicating a preserved arterial compliance, which could be the result of compensatory mechanisms, like an increased cardiac output or systemic vasodilation [ 25 , 26 ].…”
Section: Discussion
supporting
confidence: 93%